Case number# PHEH2015US018440, is an initial spontaneous report received from a nurse on 17 Sep 2015.
 This report refers to a patient of an unknown gender and age. The medical history and concomitant medication 
were not reported. 
The patient received Gilenya (fingolimod) capsule for an unknown indication (date, dose and route unknown). 
On an unknown date, the patient had low white blood cell counts (white blood cell count decreased) (value not 
provided) while on Gilenya and a low absolute count. They were kind of stable, but a little lower than the last time. 
JC Virus tested was 0.24 (jc virus test positive) and it was considered indeterminate. The reporter would like to 
know at what point the patient should discontinue the therapy with Gilenya. The action taken with Gilenya was not 
reported.
Print Time: 13-JUN-2016 09:36 AM If a field is blank, there is no data for that field Page 448 of 457
FDA - Adverse Event Reporting System (FAERS) 
FOIA Case Report Information
The outcome of the events was unknown. The seriousness and causality of the events was not reported.